New Trade for December 12th

On Friday, stocks trended higher after the U.K. reported preliminary data showing Pfizer (PFE) and BioNTech’s (BNTX) vaccine is effective against the latest COVID-19 strain.

According to the U.K. Health Security Agency (UKHSA), recent studies proved that booster shots were 70% to 75% effective in preventing serious disease from the Omicron mutation. 

The report fueled a rally across all S&P 500 Index sectors, with technology stocks leading the pack – a much-needed shift after recent volatility among high-growth stocks. 

But, more broadly speaking, this should bode well for a biotech name we’ve been tracking, as a recent drop in value could now make it the perfect time to buy…


The Truth Behind the Global Chip Shortage

Brownstone Research

GM and Toyota factories are shutting down… Mass shortages of electronics… Medical device production nearly halted… But what you probably don’t yet realize–what few so far have figured out… Is what’s really causing it. [Full Story Here…]


One of the larger biotech stocks we’re monitoring is Biogen (BIIB). The company is a multinational company that specializes in developing treatments for neurological diseases. 

While Biogen doesn’t operate in the vaccine space, the ongoing pandemic has increased the popularity and interest surrounding the industry. And these tailwinds, combined with the release of several revolutionary drugs, has helped Biogen expand its footprint in recent months.

Even so, shares of Biogen have fallen by more than 42% in the past six months due to controversy over its Alzheimer’s treatment.

Yet, despite this hit in share value, this may not be as much of a concern as headlines may have initially suggested. 

Even though many doctors have remained wary of prescribing the U.S. Food and Drug Administration-approved treatment, Aduhelm is still extremely effective at removing beta-amyloid plaque, which contributes to cognitive declines. 

And given the fact that it’s the first drug of its kind to receive approval in more than two decades, it means that it will likely remain the only plausible option for many moving forward. 


Where to invest $100 right now…

Before you consider buying BIIB, you'll want to see this.

“Penny Trades” are cheap and explosive…

Warren Buffett grabbed 46 million of them for 1¢ a pop.

Right now, he’s up as much as a rare 4,429% on this trade.

But “Penny Trades” aren’t reserved for billionaires like Buffett.

Thanks to SEC loophole 30.52, you can play them in your brokerage account.

One of these “Penny Trades” shot up 183% in one day…

Penny Trades can pay far MORE than stocks…

Our readers just saw a 19¢ trade shoot up as much as a rare 5,100%…

Here’s the #1 “Penny Trade” for RIGHT NOW.


2,000X Bigger than Bitcoin? Forbes calls THIS the Future

Legacy Research

LIVE ON CAMERA The man who called #1 tech stocks of 2016, 2018, 2019 & 2020 based on return…

Reveals the details of a new tech set to grow:

  • 113X bigger than the Internet…
  • 600X bigger than 5G…
  • 2,000X BIGGER than Bitcoin

“This is the biggest investing moment in 400 years — and just $25 gets you in.”

Brown believes the rollout could be days away… [Full Story…]

$3 EV Play No One's Talking About

This company is a sneaky EV play that no one’s talking about. They’re producing an odd variation on the traditional EV that has consumers raving.

Enter your email address to receive this company’s name and ticker symbol for free.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$30 Stock Freaking Out Billionaires

This stock is an industry leader in a robotics technology that is freaking out billionaires (trading for just $30).

Enter your email address to receive this company’s name and ticker symbol for free.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The Best TaaS Stock Right Now

This company is set to corner the market in a self-driving technology that  could fundamentally change our entire society – much like the internet did.

Enter your email address to receive this company’s name and ticker symbol for free.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Up to 20,000 IPOs All in One Day

A radical $2.1 quadrillion shift is coming to the financial markets.

Some are calling it G.T.E. and Mark Cuban, Elon Musk, Richard Branson, and even banks like J.P. Morgan are invested in the tech behind it.

Just $25 could get you in alongside these billionaires. 

Enter your email address to receive the video that reveals it all.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$2 Biotech Stock

Steve Cohen, the billionaire stock picker known for running one of the most successful hedge funds ever, has poured millions into the first stock, and it’s trading for only $2.

Enter your email address to receive this company’s name and ticker symbol for free.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works